Log in or Sign up

Professor & patients' paper on the solvable biological challenge of ME/CFS: reader-friendly version
Simon McGrath provides a patient-friendly version of a peer-reviewed paper which highlights some of the most promising biomedical research on ME/CFS ...
Discuss the article on the Forums.

Wall Street Journal - XMRV Inactivation in Blood Supply

Discussion in 'XMRV Testing, Treatment and Transmission' started by Wayne, Sep 7, 2010.

Page 2 of 2

*GG* Senior Member

Messages:

6,081

Likes:

4,669

Concord, NH

leela said: ↑

"While the FDA has traditionally said the U.S. blood supply is safe and doesn't really need a sweeping new technology to protect it"

I find this statement from the above-mentioned Cerus article to be the height of arrogance. Because they screen only for specific pathogens, they think it must be clean? One would think they would leap at a technology like this, so that the blood supply could be as safe as possible. XMRV or not,
the hubris of an attitude like that just further erodes my already crumbly opinion of FDA policy.
Click to expand...

Lovely rational, Why look out for the future bugs?! Dumb asses!!

*GG*, Sep 15, 2010

#21

(You must log in or sign up to reply here.)

Page 2 of 2

See more popular forum discussions.

Share This Page

Search